Medtronic's DBS Epilepsy Therapy Reduces Seizures 68% At Three Years

Epilepsy patients treated with Medtronic's DBS deep brain stimulation therapy had a 68% median reduction in the frequency of seizures at three years compared to baseline, according to data released Dec. 6